35986841_10216840653711318_1105697261150535680_n
Normal view MARC view ISBD view

“In-Vitro Evaluation of Synergistic Effect of Quercetin on the Anticancer Activities of 5Fluorouracil In MDA.MB231 Breast Cancer Cell Line.” // GP // Dr. Mohamed Farouk ( 2018 - 2019)

By: David Mofeed Gerges 154273.
Contributor(s): Ivodia Maged Nasif 151675 | Lamis Khaled Mohamed 153491 | Salma Mahmoud Khalil 154203.
Material type: TextTextSeries: Pharmacy Distinguished Projects 2019. Publisher: Giza MSA 2019Description: 57 P.Subject(s): CancerDDC classification: 615 Online resources: FULL TEXT HERE Summary: Breast cancer is the most commonly occurring cancer in women which causes death among women in 140 of 184 countries worldwide and the second most common cancer overall. Breast cancer characterized by the uncontrolled growth of abnormal cells in the mammary gland of the breast or in the ducts that deliver milk to the nipples. Several anticancer drugs are used in the treatment of breast cancer; 5-FU is a chemotherapeutic agent that inhibits thymidylate synthase enzyme, hence interferes with the formation of thymidylate from uracil which lead to inhibition of DNA and RNA synthesis. Quercetin is one of the most powerful flavonoids for protecting the body from reactive oxygen species by increasing the function of antioxidants. It also inhibits both cyclooxygenase and lipoxygenase activities, so decreases the formation of inflammatory metabolites. MTT-based assay revealed that the IC50 of 5-FU and Quercetin were 90.5μM and 4.8 μM respectively after 24 hours against MDA.MB231 breast cancer cell line (Mariotto et al, 2017). Besides, by using Compusyn to calculate the combination index of 5-FU + Quercetin (<0.1) it revealed very strong synergism. According to flow cytometry results, 0.5 fold IC50 combinations showed strong synergism showing the possibility of 5-FU dose reduction while maintaining the cytotoxic effects by combining it with the natural product quercetin. These results were confirmed by flow cytometry for cell cycle analysis where the 0.5 IC50 combinations gave comparable effect to the IC50 5-FU causing cell cycle arrest at G1 phase. In conclusion, the study results showed that addition of Quercetin to 5-FU synergized their individual anticancer effect.
List(s) this item appears in: Pharmacy D. G. P 2018 / 2019
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Distinguished Graduation Projects Distinguished Graduation Projects Centeral Library
Second Floor - Pharmacy
GP47PHBIOChem2019 (Browse shelf) Available 82051

Breast cancer is the most commonly occurring cancer in women which causes death among women in
140 of 184 countries worldwide and the second most common cancer overall. Breast cancer characterized
by the uncontrolled growth of abnormal cells in the mammary gland of the breast or in the ducts that
deliver milk to the nipples. Several anticancer drugs are used in the treatment of breast cancer; 5-FU is a
chemotherapeutic agent that inhibits thymidylate synthase enzyme, hence interferes with the formation of
thymidylate from uracil which lead to inhibition of DNA and RNA synthesis. Quercetin is one of the
most powerful flavonoids for protecting the body from reactive oxygen species by increasing the function
of antioxidants. It also inhibits both cyclooxygenase and lipoxygenase activities, so decreases the
formation of inflammatory metabolites.
MTT-based assay revealed that the IC50 of 5-FU and Quercetin were 90.5μM and 4.8 μM respectively
after 24 hours against MDA.MB231 breast cancer cell line (Mariotto et al, 2017). Besides, by using
Compusyn to calculate the combination index of 5-FU + Quercetin (<0.1) it revealed very strong
synergism. According to flow cytometry results, 0.5 fold IC50 combinations showed strong synergism
showing the possibility of 5-FU dose reduction while maintaining the cytotoxic effects by combining it
with the natural product quercetin. These results were confirmed by flow cytometry for cell cycle
analysis where the 0.5 IC50 combinations gave comparable effect to the IC50 5-FU causing cell cycle
arrest at G1 phase.
In conclusion, the study results showed that addition of Quercetin to 5-FU synergized their individual
anticancer effect.

There are no comments for this item.

Log in to your account to post a comment.

Click on an image to view it in the image viewer